GSK plc
GSK
#220
Rank
NZ$176.60 B
Marketcap
NZ$88.07
Share price
1.20%
Change (1 day)
32.06%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$6.64

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$6.68. In 2025 the company made an earnings per share (EPS) of NZ$6.48 an increase over its 2024 EPS that were of NZ$2.74.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.642.51%
2025NZ$6.48136.36%
2024NZ$2.74-47.35%
2023NZ$5.20-64.2%
2022NZ$14.54182.29%
2021NZ$5.15-18.07%
2020NZ$6.2822.34%
2019NZ$5.1423.9%
2018NZ$4.15140.61%
2017NZ$1.7264.45%
2016NZ$1.05-90.61%
2015NZ$11.16178.12%
2014NZ$4.01-48.11%
2013NZ$7.7322.68%
2012NZ$6.30-11.31%
2011NZ$7.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$12.06 80.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.25-66.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.40-34.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.11-8.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.94 78.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.35-64.75%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.55-108.23%๐Ÿ‡บ๐Ÿ‡ธ USA